J. B. Chemicals & Pharmaceuticals Limited

NSE JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited Dividend Yield on January 14, 2025: 0.59%

J. B. Chemicals & Pharmaceuticals Limited Dividend Yield is 0.59% on January 14, 2025, a 21.77% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.
  • J. B. Chemicals & Pharmaceuticals Limited 52-week high Dividend Yield is 0.61% on November 19, 2024, which is 3.37% above the current Dividend Yield.
  • J. B. Chemicals & Pharmaceuticals Limited 52-week low Dividend Yield is 0.46% on February 07, 2024, which is -22.26% below the current Dividend Yield.
  • J. B. Chemicals & Pharmaceuticals Limited average Dividend Yield for the last 52 weeks is 0.55%.
Key data
Date Dividend Yield Free Cash Flow Yield Earnings Yield Enterprise Value (EV)
Market news
Loading...
NSE: JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

CEO Mr. Nikhil Ashokkumar Chopra
IPO Date July 1, 2002
Location India
Headquarters Cnergy IT Park
Employees 5,311
Sector Health Care
Industries
Description

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.

Similar companies

AJANTPHARM.NS

Ajanta Pharma Limited

USD 32.53

1.58%

IPCALAB.NS

Ipca Laboratories Limited

USD 18.35

0.69%

APLLTD.NS

Alembic Pharmaceuticals Limited

USD 11.66

0.86%

ALKEM.NS

Alkem Laboratories Limited

USD 60.83

0.86%

NAVINFLUOR.NS

Navin Fluorine International Limited

USD 41.96

0.53%

StockViz Staff

January 15, 2025

Any question? Send us an email